Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#71 / 200 Total
OCEA - Ocean Biomedical Inc. - Stock Price Chart
TickerOCEA [NASD, RUT]
CompanyOcean Biomedical Inc.
CountryUSA
IndustryBiotechnology
Market Cap47.82MEPS (ttm)-3.83
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-587.66%
Dividend-Sales Q/Q-
Insider Own74.86%Inst Own13.49%
Insider Trans0.00%Inst Trans2.64%
Short Float7.39%Earnings-
Analyst Recom1.00Target Price18.50
Avg Volume6.94M52W Range0.52 - 12.08
Apr-24-24 04:51PM Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K (GlobeNewswire)
Mar-28-24 01:15PM 13 Hot Stocks to Invest in According to Wall Street Analysts (Insider Monkey) -6.77%
08:01AM Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL (GlobeNewswire)
Mar-24-24 03:52PM 5 Best Biotech Penny Stocks to Invest In (Insider Monkey)
Mar-05-24 08:30AM Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments (GlobeNewswire) +28.92%
Feb-29-24 08:01AM Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting (GlobeNewswire) +14.29%
Dec-05-23 09:45AM EXCLUSIVE: Ocean Biomedical Announces Publication of Breast Cancer Research On New Tumor Suppression Pathway for Proprietary Antibody (Benzinga)
08:15AM Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody (GlobeNewswire)
Nov-29-23 05:41PM Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q (GlobeNewswire) -8.95%
Nov-14-23 08:01AM Ocean Biomedical (NASDAQ: OCEA) Announces Positive Preclinical Oncology Data for VRON-0300, Presented at SITC 2023 Annual Meeting, and Clinical Updates by 50/50 Joint Venture Partner Virion Therapeutics (GlobeNewswire) -15.36%
SGMT - Sagimet Biosciences Inc - Stock Price Chart
TickerSGMT [NASD, RUT]
CompanySagimet Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap146.03MEPS (ttm)-1.28
P/E-EPS this Y22.63%
Forward P/E-EPS next Y-69.46%
PEG-EPS past 5Y-16.23%
P/S73.02EPS next 5Y-
P/B1.15EPS Q/Q12.87%
Dividend-Sales Q/Q-
Insider Own46.04%Inst Own37.78%
Insider Trans0.10%Inst Trans-
Short Float12.01%EarningsMar 25/b
Analyst Recom1.00Target Price42.00
Avg Volume991.23K52W Range2.13 - 20.71
TodayInitiated H.C. Wainwright Buy $32
Apr-22-24 08:00AM Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 3, 2024 (GlobeNewswire)
Mar-27-24 04:01PM Sagimet Biosciences Announces Completion of Phase 1 Hepatic Impairment Study with FASN Inhibitor Denifanstat (GlobeNewswire) +9.56%
Mar-25-24 07:00AM Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors (GlobeNewswire) +15.74%
06:15AM Sagimet Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates (GlobeNewswire)
Feb-29-24 08:00AM Sagimet Biosciences to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Jan-25-24 08:58PM Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock (GlobeNewswire) -13.62%
Jan-23-24 05:45PM Sagimet Biosciences Announces Proposed Public Offering of Series A Common Stock (GlobeNewswire)
Jan-22-24 11:10PM Gannex's Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH (PR Newswire) +170.09%
07:00AM Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH (GlobeNewswire)
Dec-04-23 08:00AM Sagimet Biosciences to Participate in the First Annual Goldman Sachs Catalyst Clinic (GlobeNewswire) +7.12%
ORGO - Organogenesis Holdings Inc - Stock Price Chart
TickerORGO [NASD, RUT]
CompanyOrganogenesis Holdings Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap331.22MEPS (ttm)0.04
P/E68.39EPS this Y-93.45%
Forward P/E30.14EPS next Y1194.37%
PEG28.38EPS past 5Y-
P/S0.76EPS next 5Y2.41%
P/B1.18EPS Q/Q-107.57%
Dividend-Sales Q/Q-13.73%
Insider Own41.43%Inst Own44.55%
Insider Trans-0.78%Inst Trans-5.27%
Short Float10.77%EarningsMay 09/a
Analyst Recom1.67Target Price4.83
Avg Volume849.24K52W Range1.88 - 4.70
Today 07:00AM Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis (GlobeNewswire)
Apr-16-24 07:30AM Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024 (GlobeNewswire)
Apr-03-24 07:30AM Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case (GlobeNewswire) +6.13%
Mar-02-24 08:39AM Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 06:29PM Why Organogenesis Holding Stock Plummeted by 18% Today (Motley Fool) -18.21%
Feb-29-24 05:45PM Organogenesis (ORGO) Reports Break-Even Earnings for Q4 (Zacks)
04:50PM Organogenesis: Q4 Earnings Snapshot (Associated Press Finance)
04:38PM Organogenesis Holdings Inc (ORGO) Faces Revenue Decline in Q4 and FY 2023, Aims for Growth in 2024 (GuruFocus.com)
04:05PM Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance (GlobeNewswire)
Feb-12-24 07:30AM Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference (GlobeNewswire) +5.21%
PLTN - Plutonian Acquisition Corp - Stock Price Chart
TickerPLTN [NASD]
CompanyPlutonian Acquisition Corp
CountryUSA
IndustryShell Companies
Market Cap35.50MEPS (ttm)0.11
P/E66.23EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.13EPS Q/Q-386.86%
Dividend-Sales Q/Q-
Insider Own34.07%Inst Own61.24%
Insider Trans0.00%Inst Trans-
Short Float0.05%Earnings-
Analyst Recom-Target Price-
Avg Volume36.47K52W Range7.75 - 11.16
Today 07:37AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) -22.40%
May-01-24 08:25AM Why Is Plutonian Acquisition (PLTN) Stock Up 27% Today? (InvestorPlace)
07:31AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
Feb-05-24 06:30AM Plutonian Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination (PR Newswire)
Nov-15-23 06:00AM Plutonian Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination (PR Newswire)
Oct-10-23 08:54PM Big Tree Cloud Enters into Definitive Merger Agreement with Plutonian Acquisition Corp. (Nasdaq: PLTN) (PR Newswire)
SMXT - SolarMax Technology Inc. - Stock Price Chart
TickerSMXT [NASD]
CompanySolarMax Technology Inc.
CountryUSA
IndustrySolar
Market Cap449.27MEPS (ttm)0.01
P/E1028.35EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S8.30EPS next 5Y-
P/B-EPS Q/Q-89.27%
Dividend-Sales Q/Q-15.21%
Insider Own39.30%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float0.30%Earnings-
Analyst Recom-Target Price-
Avg Volume289.04K52W Range3.50 - 15.88
Apr-16-24 07:35PM SolarMax Technology, Inc. Reports Fiscal Year 2023 Financial Results (ACCESSWIRE) -18.58%
Apr-11-24 05:00AM 4 Stocks For A Decarbonized Future (News Direct) +14.90%
Mar-05-24 04:01PM SolarMax Technology, Inc. Announces Exercise of Overallotment Option From Initial Public Offering (GlobeNewswire) +12.88%
Feb-29-24 01:30PM SolarMax Technology, Inc. Announces Closing of Initial Public Offering (GlobeNewswire) -16.55%
Feb-27-24 12:51PM SolarMax Technology, Inc. Announces Pricing of Initial Public Offering and listing on Nasdaq (PR Newswire)
BNTC - Benitec Biopharma Inc - Stock Price Chart
TickerBNTC [NASD]
CompanyBenitec Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap22.92MEPS (ttm)-10.90
P/E-EPS this Y82.79%
Forward P/E-EPS next Y27.98%
PEG-EPS past 5Y66.41%
P/S382.03EPS next 5Y-
P/B1.48EPS Q/Q20.94%
Dividend-Sales Q/Q-100.00%
Insider Own6.81%Inst Own46.32%
Insider Trans0.00%Inst Trans-
Short Float0.51%EarningsFeb 13/b
Analyst Recom1.00Target Price16.00
Avg Volume86.50K52W Range1.86 - 9.01
May-01-24 08:00AM Benitec Biopharma to Participate in the Citizens JMP Life Science Conference (GlobeNewswire) -6.51%
Apr-18-24 07:30AM Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study (GlobeNewswire) +42.08%
07:00AM Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million (GlobeNewswire)
Apr-09-24 08:00AM Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024 (GlobeNewswire)
Mar-24-24 07:55AM 11 Best ASX Stocks To Buy Now (Insider Monkey)
Feb-13-24 08:00AM Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire)
Nov-30-23 07:00AM Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy (GlobeNewswire)
Nov-17-23 08:00AM Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-13-23 08:00AM Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire)
Sep-21-23 08:00AM Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational Update (GlobeNewswire)
DGII - Digi International, Inc. - Stock Price Chart
TickerDGII [NASD, RUT]
CompanyDigi International, Inc.
CountryUSA
IndustryCommunication Equipment
Market Cap977.85MEPS (ttm)0.38
P/E71.23EPS this Y3.04%
Forward P/E11.85EPS next Y10.97%
PEG4.19EPS past 5Y62.66%
P/S2.23EPS next 5Y17.00%
P/B1.80EPS Q/Q-32.75%
Dividend-Sales Q/Q-3.10%
Insider Own3.13%Inst Own100.37%
Insider Trans0.00%Inst Trans5.38%
Short Float7.42%EarningsMay 01/a
Analyst Recom1.00Target Price39.33
Avg Volume160.62K52W Range21.25 - 42.95
Today 06:27AM Digi International Fiscal Q2 Adjusted Earnings, Revenue Decline (MT Newswires) -12.21%
May-01-24 08:54PM DGII Stock Earnings: Digi Intl Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
07:10PM Digi International (DGII) Q2 Earnings and Revenues Top Estimates (Zacks)
06:13PM Digi International Inc (DGII) Reports Mixed Q2 Fiscal 2024 Results, Aligns with EPS Projections (GuruFocus.com)
06:05PM Digi International: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:35PM Digi International Reports Second Fiscal Quarter 2024 Results (Business Wire)
Apr-23-24 07:55AM Dont Miss the Boat! 7 Stocks That Can Change Your Life by 2030 (InvestorPlace)
Apr-17-24 09:00AM Digi International Reveals 2024 Green Tech Customer Innovation Award Winners (Business Wire)
Apr-16-24 09:00AM Digi International Expands Monitoring Portfolio with Launch of Digi Connect Sensor XRT-M Powered by Digi Axess (Business Wire)
Apr-08-24 04:05PM Digi International to Release Second Fiscal Quarter 2024 Earnings Results on May 1, 2024 and Host a Conference Call on May 2, 2024 (Business Wire)
WOLF - Wolfspeed Inc - Stock Price Chart
TickerWOLF [NYSE]
CompanyWolfspeed Inc
CountryUSA
IndustrySemiconductors
Market Cap2.77BEPS (ttm)-6.41
P/E-EPS this Y-247.30%
Forward P/E-EPS next Y9.74%
PEG-EPS past 5Y1.17%
P/S3.29EPS next 5Y-
P/B2.41EPS Q/Q-47.99%
Dividend-Sales Q/Q-12.24%
Insider Own2.05%Inst Own109.65%
Insider Trans0.79%Inst Trans-2.22%
Short Float16.43%EarningsMay 01/a
Analyst Recom2.57Target Price33.39
Avg Volume4.74M52W Range21.85 - 70.42
TodayDowngrade William Blair Outperform → Mkt Perform
TodayDowngrade TD Cowen Buy → Hold $40 → $25
Today 10:35AM Q3 2024 Wolfspeed Inc Earnings Call (Thomson Reuters StreetEvents) -15.53%
10:33AM Wolfspeed, Inc. (NYSE:WOLF) Q3 2024 Earnings Call Transcript (Insider Monkey)
07:55AM Morgan Stanley Trims Price Target on Wolfspeed to $26 From $27, Keeps Equalweight Rating (MT Newswires)
07:37AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
06:58AM William Blair Downgrades Wolfspeed to Market Perform From Outperform (MT Newswires)
May-01-24 08:55PM WOLF Stock Earnings: Wolfspeed Beats EPS, Misses Revenue for Q3 2024 (InvestorPlace)
06:00PM Wolfspeed (WOLF) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
05:51PM Wolfspeed Inc (WOLF) Q3 Fiscal 2024 Earnings: Aligns with Revenue Projections Amid Operational ... (GuruFocus.com)
05:22PM Chipmaker Wolfspeed forecasts quarterly revenue below estimates as EV sales growth slows (Reuters)
04:55PM Wolfspeed: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
ULCC - Frontier Group Holdings Inc - Stock Price Chart
TickerULCC [NASD, RUT]
CompanyFrontier Group Holdings Inc
CountryUSA
IndustryAirlines
Market Cap1.32BEPS (ttm)-0.06
P/E-EPS this Y215.55%
Forward P/E6.88EPS next Y126.38%
PEG-EPS past 5Y-
P/S0.37EPS next 5Y-
P/B2.60EPS Q/Q-191.69%
Dividend-Sales Q/Q-1.66%
Insider Own47.17%Inst Own31.28%
Insider Trans-0.86%Inst Trans-4.10%
Short Float10.23%EarningsMay 02/b
Analyst Recom2.83Target Price7.95
Avg Volume2.10M52W Range3.19 - 10.57
Today 10:00AM Compared to Estimates, Frontier Group (ULCC) Q1 Earnings: A Look at Key Metrics (Zacks)
09:23AM Frontier Airlines CEO Barry Biffle on Q1 results, state of consumer and BizFare launch (CNBC TV)
08:00AM Frontier Group Holdings (ULCC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
06:50AM Frontier Airlines Reports First Quarter 2024 Financial Results (PR Newswire)
Apr-25-24 10:02AM Analysts Estimate Frontier Group Holdings (ULCC) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-22-24 09:58AM The Way Airlines Charge for Bags Is Becoming More Complex and Expensive (The Wall Street Journal)
05:30AM You Cant Just Book Your Flight and Ignore the Bag Fees Anymore (The Wall Street Journal)
Apr-18-24 08:00AM Frontier Group Holdings Announces Webcast of First Quarter 2024 Financial Results (PR Newswire)
Mar-29-24 02:05PM Indigo Partners Announces Plans to Distribute Frontier Group Holdings Common Stock to its Limited Partners (PR Newswire)
Mar-15-24 05:22PM Younger travelers are planning more, even turning to travel agents (Yahoo Finance Video)
SHMD - SCHMID Group N.V. - Stock Price Chart
TickerSHMD [NASD]
CompanySCHMID Group N.V.
CountryCayman Islands
IndustryElectronic Components
Market Cap48.88MEPS (ttm)-0.12
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.38EPS Q/Q-100.11%
Dividend-Sales Q/Q-
Insider Own-Inst Own43.28%
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume69.53K52W Range4.61 - 11.50
May-01-24 09:35AM SCHMID Group Closes Business Combination and Begins Trading on the Nasdaq Stock Exchange (GlobeNewswire) -19.17%
1⋯345678910111213⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.